全部资讯｜CELL INTELLIGENCE

ALL SOURCES

全部资讯 4

把在研试验和前沿论文合在一起看，按时间倒序排列。本页条数 = 前沿论文 + 临床试验两块之和（导航里的「临床试验」板块只收在招的那部分，不另计入）。

Chimeric Antigen Receptor-Immune Cell-Based Therapies for Clear Cell Renal Cell Carcinoma: Latest Advancements and Directions.

PubMed 2026/06/24 发表Cancers (Basel)Q2 · IF 4.8（JCR 2025）

Efficient, fratricide free non-viral engineering of CD70-targeted CAR NK cells for hematologic and solid tumor immunotherapy.

PubMed 2026/04/09 发表Mol Ther Adv

CD70-targeted iPSC-derived CAR-NK cells display potent function against tumors and alloreactive T cells.

PubMed 2025/01/09 发表Cell Rep MedQ1 · IF 14（JCR 2025）

Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma.

PubMed 2022/07/18 发表Cancer ResQ1 · IF 22.6（JCR 2025）